Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Latest filing published 16 Oct 2026 for CytomX Therapeutics, Inc., €141k. Read the official filing
Filing timeline
BuySaleSean A. McCarthy
Insider track record
Disclosed buys
0
Disclosed sells
41
Signal history
Sean A. McCarthy: trading record in brief
Sean A. McCarthy, listed as chief executive, appears in our data through filings on CytomX Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 100 filings, for trades running from 30 November 2016 to 17 March 2026.
On the market, this insider has only sold: 41 sales, €7.4M in total. Outside the open market, there are 16 share grants and 42 option exercises. 2026 to date brings no purchases and 2 sales.
The record was last updated on 16 October 2026 with an open-market sale (€402k) in CytomX Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sean A. McCarthy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
101,793 shares@ US$1.59Common StockSEC:0001610717-26-000442:0
101,793 shares@ US$4.5377Common StockSEC:0001610717-26-000442:1
118,969 shares@ US$6.42332.0% of flowCommon StockSEC:0001610717-26-000124:0
210,000 shares0Common StockSEC:0001610717-26-000039:0
101,793 shares@ US$4.537719.4% of flowClass A Common StockSEC:0001610717-25-000372:0
150,000 shares0Common StockSEC:0001610717-25-000234:0
37,656 shares@ US$0.5991.0% of flowCommon StockSEC:0001610717-25-000086:0
180,000 shares0Common StockSEC:0001610717-25-000016:0
37,500 shares0Common StockSEC:0001610717-24-000432:0
109,768 shares@ US$1.57497.7% of flowCommon StockSEC:0001610717-24-000190:0
20,223 shares@ US$2.08551.9% of flowCommon StockSEC:0001610717-24-000178:0
90,000 shares0Common StockSEC:0001610717-24-000036:0
13,551 shares@ US$1.38070.8% of flowCommon StockSEC:0001610717-23-000423:0
37,500 shares0Common StockSEC:0001610717-23-000411:0
40,000 shares0Common StockSEC:0001610717-23-000297:0
16,535 shares@ US$1.57491.2% of flowCommon StockSEC:0001610717-23-000061:0
7,121 shares@ US$1.88050.6% of flowCommon StockSEC:0001140361-23-012618:0
105,000 shares0Common StockSEC:0001567619-23-001930:0
40,000 shares0Common StockSEC:0001567619-22-014299:0
66,742 shares@ US$0.9452.9% of flowCommon StockSEC:0001567619-22-010091:0
75,000 shares0Common StockSEC:0001567619-22-002521:0
92,113 shares@ US$1.13394.3% of flowCommon StockSEC:0001567619-21-015554:0
100,000 shares@ US$7.044728.3% of flowCommon StockSEC:0001567619-21-012419:0
30 shares@ US$1.13390.0% of flowCommon StockSEC:0001567619-21-012252:0
4,500 shares0Common StockSEC:0001567619-21-011808:0
25 of 25 declarations
